Archive: August 11 2020
For immunotherapy to deliver on its promise, affordable and equitable access for patients across Europe must be ensured. Close collaboration between stakeholders is crucial, as is European coordination and harmonization on all aspects that affect availability and uptake: from clinical trials and precision diagnostics to training and guidelines.
